GCA & Steroid Weaning

RheumNow

J. Cush

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Are 14-3-3 Proteins Important Antigens in Large Vessel Vasculitis?

Cleveland Clinic Rheumatology

L. Calabrese, G. Hoffman

Abstract Discussions: Osteoporotic Fractures in Postmenopausal Women…

RheumNow

J. Pope

72 y/o Female With Giant Cell Arteritis, Polymyalgia Rheumatica, and…

Vanderbilt University Medical Center (VUMC)

K. Byram

When Should Biologic Agents be Introduced in Giant Cell Arteritis an…

Cleveland Clinic Rheumatology

K. Warrington

Introduction to Ultrasound in Large Vessel Vasculitis - How to Corre…

University of Washington School of Medicine

W. Schmidt

EULAR® 2024 Insights: Ultrasound of Peripheral Arteries in GCA

EULAR® 2024 Insights

W. Schmidt

Cleveland Clinic 2020 ACR Update on GCA: Is Tocilizumab + Ultra-Shor…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

ACR Convergence 2023 Highlights: Tocilizumab vs Methotrexate in Gian…

Highlights from ACR Convergence 2023

E. Treppo

Rheumatic IO Related irAEs: Are Rheumatogists Best Equipped to Manag…

Cleveland Clinic Rheumatology

L. Calabrese

The Cat in Wolves Clothing – Is It ANCA Vasculitis or Bartonella & M…

Cleveland Clinic Rheumatology

A. Brown

Historical Considerations of Vasculitis, Lupus and Autoimmune Diseas…

Keck School of Medicine of USC

R. Panush

A Case of GPA With Persistent Shortness of Breath, Monitoring Patien…

Cleveland Clinic Rheumatology

A. Villa-Forte

Therapy of GCA and PMR in 2024

Hospital for Special Surgery

R. Spiera

EULAR Daily Recap: Day 4

RheumNow

D. Liew, A. Najm, J. Cush

2020 ACR Update on Giant Cell Arteritis: Is Mavrilimumab Effective f…

RheumNow

S. Mackie, D. Liew, R. Conway, L. Calabrese

PMR/GCA Panel EULAR 2022

RheumNow

R. Conway, S. Mackie, M. Putman

Management of Rheumatic irAEs: Is ICI Therapy Safe For Patients With…

Cleveland Clinic Rheumatology

C. Calabrese

Select Your GCA Therapy

RheumNow

D. Liew